Physician profile
Syed Z Rizvi
NPI 1407032188
$3,599.10
in general payments reported to CMS, 2019-2025
27 companies · $687 in 2025
The $687 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $175 · 2021: $260 · 2022: $680 · 2023: $1,300 · 2024: $200 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,658 · Travel and Lodging: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,658.48 |
| Travel and Lodging | $527.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $748.97 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kerecis Limited | $550.05 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $355.99 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Revcore Thrombectomy Catheter |
| Silk Road Medical, INC. | $315.21 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.35 | 2020-2022 | |
| Medtronic Vascular, INC. | $196.86 | 2019-2020 | |
| Bsn Medical INC | $186.48 | 2023 | |
| W. L. Gore & Associates, INC. | $180.84 | 2021-2025 | Gore Tag Conformable Thoracic Stent Graft |
| Endologix LLC | $149.63 | 2025 | Torus Stent Graft System, Endocross Device |
| Janssen Pharmaceuticals, INC | $149.34 | 2019-2023 | Xarelto |
| Venclose INC. | $78.78 | 2020 | |
| Tactile Systems Technology INC | $77.21 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Lemaitre Vascular, INC. | $68.21 | 2023-2024 | Restoreflow |
| Cook Medical LLC | $60.55 | 2023 | Cook, Zenith |
| Boston Scientific Corporation | $42.99 | 2021-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $40.22 | 2023 | Puraply |
| Surmodics, INC. | $30.01 | 2022 | |
| Polynovo North America LLC | $28.81 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.95 | 2019 | |
| Baxter Healthcare | $18.89 | 2022 | |
| Acera Surgical, INC. | $18.23 | 2022 | |
| Convatec INC. | $17.37 | 2023 | |
| Shockwave Medical, INC | $17.00 | 2025 | |
| Pfizer INC. | $13.75 | 2021 | |
| Medtronic, INC. | $11.69 | 2022 | |
| Melinta Therapeutics, LLC | $11.58 | 2019 | |
| Bolton Medical INC | $8.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Rizvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.